Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Mitomycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 366,984Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ENVISION Trial Shows 82.3% Response Duration for UGN-102
    ENVISION Trial Shows 82.3% Response Duration for UGN-102

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241028821933/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    UroGen Announces FDA Acceptance of its NDA for UGN-102
    UroGen Announces FDA Acceptance of its NDA for UGN-102

    15 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241015921667/en

    BUSINESSWIRE
    15 Oct 2024
    Share Share
    UroGen Receives Patent For Next-Gen Mitomycin Products
    UroGen Receives Patent For Next-Gen Mitomycin Products

    16 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240916912176/en

    BUSINESSWIRE
    16 Sep 2024
    Share Share
    UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    07 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240607623862/en

    BUSINESSWIRE
    07 Jun 2024
    Share Share
    UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024
    UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024

    06 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240606674853/en

    BUSINESSWIRE
    06 Jun 2024
    Share Share
    UroGen Pharma Appoints David Lin as New Chief Commercial Officer
    UroGen Pharma Appoints David Lin as New Chief Commercial Officer

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603331264/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share